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Abstract:
In February 2001, the European Commission published its White Paper on a Strategy for a
Future  Chemicals  Policy.  The  publication  launched  a  heated  debate  on  principles,  aims,
instruments, implementation, and management of future chemicals control in the European
Communities.  The  White  Paper  came  in  wake  of  massive  criticism  of  current  chemicals
legislation. Various parties involved repeatedly expressed their concern about a tremendous
lack of effectiveness. Furthermore, comparisons with other industrialized countries outside
the EU indicated that the current regulatory framework actually discourages innovation in the
European chemicals industry. This paper examines current European chemicals policy and
main elements of the White Paper strategy with a special focus on the impact of chemicals
regulation on innovation towards sustainability. The claim that chemicals regulation tends to
block innovation is rejected for lack of conclusive proofs. In contrast, the paper reinforces the
view that the White paper strategy is an important step forward towards sustainability in the
chemicals  sector.  However,  with  the  aim  to  make  it  pay  for  companies  to  pursue
environmentally orientated innovation strategies, supporting measures and instruments need
to be developed further.
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In February 2001, the European Commission launched a far-reaching debate on exactly what
form its policy for controlling chemicals should take by publishing its White Paper on the
Strategy for a future Chemicals Policy. The White Paper is the culmination for the present of
a three-year evaluation phase  of  European  chemicals  policy  known  as  the  EU  Chemicals
Review. The reform mooted by the White Paper has been welcomed on the whole by the EU’s
Council of Environment Ministers, the Member states of the EU, the chemical industry and
other stakeholders. During the past 12 months heated discussion has taken place over the
reform proposals contained in the White Paper, which are ultimately designed to change the
very direction of European chemicals policy. At the June 2001 public hearing organised by
the  European  Parliament,  the  representative  of  the  VCI  (Verband  der  Chemischen
Industrie / German  Association  of  the  Chemical  Industry)  stated  that  rarely  before  had  a
political initiative generated so much attention and so much concern for chemical companies
as the change of tack intended for European chemicals policy. The White Paper will shortly
be followed by proposals for new chemicals legislation at Community level.
The EU’s White Paper came in the wake of massive criticism of current chemicals legislation,
whose lack of effectiveness was repeatedly criticised by various parties, most notably several
Member  states.  Furthermore,  international  comparative  studies  indicated  that  the  current
regulatory  pattern  actually  discourages  innovation  on  the  part  of  the  European  chemical
industry in a number of ways.
Therefore, this examination of European chemicals policy will focus on the effect regulation
has on innovation towards sustainability
1. It starts by summing up experience of the current
European chemicals policy, and then outlines the main reforms of the strategy behind the
proposed chemicals policy based on the European Commission’s White Paper. It concludes
by  assessing  the  extent  to  which  this  restructuring  of  European  chemicals  policy  will
encourage innovation.
2. The current regulatory pattern of European chemicals control
Over  the  past  30  years,  policy-making  for  chemicals  control  has  almost  completely  been
transferred to the European level. European chemicals regulation began back in 1967 with the
Europe-wide  harmonisation  of  legal  and  administrative  regulations  for  the  classification,
labelling and packaging of dangerous substances, at first solely for the purpose of protecting
human health. The Europeanisation of chemicals law then took place in three stages starting
off with Directive 67/548/EEC (Köck 2001: 303):
                                                
1  This  paper presents  an  outcome  of  the  ongoing  project  "Impacts  of  Chemicals  Regulation  on  Innovation
towards Sustainability". The project is funded by the German Federal Minister for Education and Research" as
part of its "RIW" research program on "Frameworks for Innovation towards Sustainability", supervised by "GSF
project management for environment and climate" – grant no. 07 RIW 2A, 2B, 2C.4
1)  The sixth amendment to Directive 67/548/EEC dated 18 September 1979 which came into
force  on  18  September  1981  introduced  a  notification  procedure  for  new  chemical
substances about to be launched onto the market involving testing requirements on the
part of the applicant. It also included the environment for the first time as a second aim of
protection alongside human health.
2)  The testing and labelling requirements were increased and uniform principles introduced
for official risk assessment in the seventh amendment in 1992. Moreover, notifications of
new  chemical  substances  in  one  Member  state  were  deemed  to  apply  throughout  the
European Community.
3)  The  Directive  covering  existing  chemicals  which  came  into  force  on  23  March  1993
placed existing chemicals – i.e. all chemicals which were declared to be on the EU market
on  or  before  18  September  1981  and  listed  in  the  EINECS  (European  Inventory  of
Existing Chemical Substances) – under the control of the European Community. Existing
chemicals  are  not  subject  to  the  notification  procedure;  instead  manufacturers  and
importers have to provide the competent authorities with the available chemicals’ basic
data  depending  on  the  volumes  in  which  they  are  produced  or  imported.  Only  some
chemicals which have been set on priority lists continue to be governed by data provision
and testing obligations.
The current basic structural feature of European chemicals regulation is the dual system of
procedures for new and existing substances. The procedure for the control of chemicals is
divided into three main stages: provision of data , risk assessment and risk management. The
first stage is controlled by Directive 67/548 for new substances, and Regulation 793/93 for
existing ones; the second by Directive 93/67 and Regulation 1488/94; while the third stage is
controlled in both cases by Directive 76/769, which limits marketing and use of dangerous
substances. During the first , information gathering stage, the manufacturer or importer is
obliged to provide a certain amount of information – depending on the chemical’s annual
production/import quantities – on its properties relevant for risk assessment. These obligations
have to be met for new substances prior to their launch on the market, i.e. the chemicals have
to be notified first. By contrast, chemicals already available on the market can continue to be
sold,  the  information  obligations  being  conducted  simultaneously  (Winter  2000:  248).
Information procurement is initially followed by an official risk assessment , which forms the
basis for any restrictions on marketing and use. Whereas administratively speaking the first
two stages are the responsibility of DG Environment, decisions concerning the third stage are
up to DG Enterprise.
2.1 The procedure for new substances
Ever since the sixth amendment to Directive 67/548  came into force in September  1981,
chemicals have legally been divided in the European Union into existing and new substances.
The term ‘new chemicals’ applies to all chemicals not listed in the EINECS. New chemicals
which are sold in an amount exceeding 10 kg per annum must be notified in the EU before5
they can be marketed. The extent of testing to determine the dangerous characteristics of new
substances depends on their marketing volume (Table 1) and covers their physico-chemical,
toxicological and ecotoxicological properties.
Table 1: Quantity thresholds for the notification of new substances
Marketing volumes
Per annum Total per manufacturer
Type of notification
10 kg < 100 kg - Reduced notification dossier
100 kg < 1 t ≥  500 kg Reduced notification dossier
≥ 1 t ≥  5 t Base set of data
≥ 100 t ≥  500 t Level 1
≥ 1,000 t ≥  5,000 t Level 2
The  testing  requirements  for  small  quantities  of  chemicals  concentrate  on  acute  hazards,
whereas those for high-production volume substances include effects of long-term exposure
such as properties that are carcinogenic, mutagenic, or toxic for reproduction. The set of test
data required for chemicals with a marketing volume exceeding 1 tonne is referred to as the
‘base set’.
Around 2,700 new substances have been notified in the EU since 1981. In the first few years
following the introduction of the Directives, hardly more than a dozen new substances were
notified each year. However, in the second half of the 1990s, notifications of new substances
rose to an annual average of 300. Sixty per cent of new substances are marketed in quantities
of between 1 and 10 tonnes, about 30 per cent in quantities less than a tonne, and about 10 per
cent  exceed  10  tonnes.  Just  under  3  per  cent  of  new  substances  are  marketed  in  annual
quantities exceeding 100 tonnes, while merely 0.6 per cent are sold in volumes exceeding
1,000 tonnes.
2 Some 70 per cent of all new chemicals are classified as dangerous, the two
properties most frequently relevant being ‘irritating’ and ‘dangerous for the environment’. Of
the 1,000 new chemicals notified in Germany by 1997, 514 were classified as irritating, or
sensitising substances, while 502 were classified as dangerous for the environment (BMU
1998).
3
On the whole, the procedure for new substances enjoys a  relatively  good reputation. The
European Commission’s report reviewing European chemicals policy describes the results of
regulation as “satisfactory”, while an evaluation under the SLIM initiative
4 concludes that all
in all the system functions up to standard (COM 2000: 8). Unfortunately, in both cases exactly
                                                
2 Cf. the website of the European Chemicals Bureau: http://ecb.jrc.it.
3 The total number of classifications is higher than the number of chemicals owing to multiple labelling.
4 SLIM stands for “Simpler Legislation for the Internal Market” – an initiative by the Commission designed to
simplify legal regulations on the single market.6
what criteria were used to judge the success of the Directive and how the reports’ authors
reached  their  conclusions  are  unclear.  This  positive  opinion  appears  to  be  based  on  the
creation of a good stock of data on the new chemicals, enabling risk assessment. However,
both reports independently concluded that reform is needed regarding the Directive’s overall
structure,  as  well  as  that  the  complex  system  of  classification  and  labelling  needs  to  be
simplified,  and  that  the  division  of  working  procedures  and  responsibilities  among  the
Member  states,  the  European  Chemicals  Bureau,  the  European  Commission  and
manufacturers need to be reorganised.
2.2. The procedure for existing chemicals
Whereas under Directive 67/548 new substances are to be tested and assessed in terms of their
dangerousness for human health and the environment, existing ones are not subject to the
same testing requirements. The control of existing substances at European level began in 1993
with Regulation 793/93 dated 23 March 1993 on the evaluation and control of the risks of
existing  chemicals.  Its  aim  is  for  information  on  existing  substances  to  be  compiled,
distributed and made accessible, and for the risks of existing substances for humans and the
environment to be properly assessed so that risks can be better dealt with.
Previous years have seen continuing discussion over reforming European chemicals policy.
One cause of concern has always been the lack of effectiveness of the regulations covering
existing substances.
5 The EINECS lists 100,195 substances, about 30,000 of which are sold in
annual  quantities  exceeding  1  tonne  (COM  2001:  4).  Of  this  amount,  20,000  are  sold  in
quantities of 1–10 tonnes every year; 5,000 of the substances have annual production levels
exceeding  100  tonnes,  and  2,500  of  them  are  produced  in  quantities  of  more  than  1,000
tonnes.  This  underlines  the  striking  numerical  imbalance  between  existing  and  new
substances,  as  well  as  the  scale  of  the  problem  regarding  existing  chemicals.  Existing
chemicals make up more than 99 per cent of the total amount of chemicals substances on the
market which may in principal be freely bought and used.
The  EU’s  Regulation  on  existing  substances  tries  to  deal  with  the  problem  of  existing
substances in four steps: data collection, priority setting, risk assessment and measures for risk
reduction. The first phase – collecting available information, initially for existing substances
produced or imported in quantities exceeding 1,000 tonnes annually, and later for existing
chemicals in quantities of 10–1,000  tonnes  –  is  now  complete.  The  database  for  existing
substances marketed in large volumes is maintained by the ECB. Existing chemicals with a
marketing volume exceeding 1,000 tonnes, whose data are incomplete (necessitating further
testing),  or  whose  available  data  indicate  the  need  for  regulation,  are  in  the  second  step
                                                
5 In December 1997, the Netherlands’ delegation to the EU Council of Environment Ministers submitted a
declaration expressing its concern at the considerable shortcomings in the implementation of Regulation 793/93
on existing substances in the previous two years. The main reasons were cited as the ECB’s lack of resources,
excessively  rigid  procedures  and  red  tape,  and  the  Regulation’s  lack  of  enforceability.  This  position  was
supported by Denmark and Germany (EU Council of Environment Ministers, Brussels 16/12/1997 – Press: 399
no. 13373/97).7
included on a priority list. Since 1994, the European Commission has passed four priority lists
with a total of 140 existing substances.
6 The third and fourth steps (risk assessment of priority
substances and measures for risk reduction) have not yet been completed.
So far, the Regulation on existing substances has on the whole proved unsatisfactory and
exhibits considerable weak points. Whereas the priority lists under the Regulation for existing
substances  have  so  far  been  limited  to  just  a  few  substances,  there  is  a  general  lack  of
knowledge concerning hazardous properties and use patterns of existing chemicals (Allanou,
Hansen,  van  der  Bilt  1999).  Current  knowledge  of  toxicological  and  ecotoxicological
characteristics as well as behaviour in the environment are even unsatisfactory for adequate
risk assessment for numerous existing substances sold in large quantities (over 1,000 tonnes
annually) with high human and environmental exposure. Not enough is known about their
main purposes either, since under current legislation only the manufacturers and importers of
chemicals – but not the subsequent users – are obliged to provide information about how they
are used. The complex procedure of  risk assessment places a considerable burden  on  the
competent  authorities  of  the  individual  Member  states,  the  European  Commission  and  in
particular the ECB.
The  criticism  that  the  procedure  for  controlling  existing  substances  is  too  lengthy  is
underlined by a glance at the figures.
7 By the end of 2001, the Member states had submitted a
draft proposal for risk assessment for 88 of the 140 existing substances listed in the first four
priority lists under the existing chemicals Regulation. Conclusive risk assessment had been
drawn  up  for  56  of  these  88  substances,  while  further  risk  reduction  measures  had  been
deemed necessary for 45 substances. Initial proposals for risk reduction strategies existed for
24 of these 45 substances. Only 11 existing substances had by this time completed the entire
assessment procedure specified by Regulation 793/93. A period of 18–29 months passes from
the  publication  of  a  priority  list  until  an  initial  draft  risk  assessment  is  submitted  to  the
Technical Committee. Discussion and agreement until final risk assessment take another nine
months (KOM 1998: 13). According to the European Commission’s report, the main reasons
for this delay are the lengthy, difficult stages and procedures specified by the Regulation such
as the selection of chemicals for the priority lists, the choice of reporting Member state, data
collection, risk assessment, technical evaluation of the risk assessment reports, and drawing
up strategies for risk reduction (KOM 1998: C22). According to current opinion, the control
of existing substances has become bogged down in the ponderous procedures of information
gathering, assessment and decision-making (Köck 2001: 304). Another complicating factor is
that the Regulation does not provide any deadlines for  risk assessment  or  possibilities  of
sanctions. This poor incentive structure has meant that in practice member states and industry
are  often  poorly  motivated  to  participate.  Furthermore,  under  the  current  regulations  the
authorities have to provide convincing reasons before restrictive measures can be introduced.
                                                
6 For more details on the four priority lists of the Regulation on existing substances between 1994 and 2000 see
the following EU Directives: (EC) 1179/94, (EC) 2268/95, (EC) 143/97, (EC) 2364/2000.
7 Cf. the ECB’s website: http://ecb.jrc.it.8
This is difficult since the current system does not provide any incentive for the industry to
support assessment. On the contrary: delaying the procedure is rewarded by the substance
being allowed to remain on the market (Winter 2000: 267; COM 2001: 19).
2.3 Risk assessment
The test data already provided by industry form the joint basis for two different but closely
interconnected  elements  of  chemical  regulation.  One  of  these  is  the  classification  and
labelling  of  chemicals  by  certain  hazardous  properties,  while  the  other  is  the  regulatory
assessment of the risks they pose. The principles of risk assessment were initially stipulated in
1993 and 1994 separately for existing and new substances respectively (Regulation 1488/94
and Directive 93/67), although in fact there are only minor differences. Consequently, the
European Commission harmonised the instructions, uniting them in 1996 within the 700-page
Technical Guidance Document (European Commission 1996). Risk assessment boils down to
comparing a chemical’s possible harmful effects and the reasonably assumed  exposure of
humans and the environment to it. The assessment procedure is therefore divided into three
main steps:
i)  ‘Effect  assessment’,  i.e.  identifying  the  harmful  effects  a  certain  substance  may
cause  and  if  necessary  determining  the  concentration-effect  or  dose-effect
relationships for these effects;
ii)  ‘Exposure assessment’, i.e. estimating the concentrations or doses of a substance to
which  humans  are  or  could  be  exposed  and  which  occur  or  could  occur  in
environmental compartments such as water, soil and air;
iii) ‘Risk characterisation’, i.e. estimating the probability of harmful effects occurring
with the predicted or actual exposure levels. This risk characterisation is carried out
separately for humans and the environment, including for different types of effects
and exposure pathways.
The  first  step  is  largely  the  same  as  the  procedure  for  the  classification  of  dangerous
substances, while steps two and three make the difference between hazard assessment and risk
assessment.
Major limitations are imposed on the possibilities for risk assessment by the specification of
testing requirements and methods. The risk of effects which are not the subject of testing or
which cannot be identified with the methods used cannot of course be assessed. The most
prominent examples in this respect are the hormone-like effects of environmental chemicals
observed  in  humans  and  animals  for  which  so  far  no  standardised  test  procedures  are
available. On the other hand, risk assessment may be superfluous if the tests carried out do not
indicate any hazardous effects – which appears to be the case for around 30 per cent of new
substances.
The  establishment  of  test  criteria  and  methods  already  contains  the  explicit  or  implicit
weighing-up of a series of conflicting demands, especially:9
i)  Low time and resources;
ii)  Minimising animal testing;
iii) Low variance, high reproducibility and good comparability of data;
iv) The relevance of the results for the risk to be assessed and the protection goals to be
achieved.
The minimum requirements in the EU for a stock of data for risk assessment meeting (at least
partly) the comprehensive aim of protecting humans and the environment are defined by the
‘base set’. The average costs of drawing up a base set have been quoted by the European
Commission at €85,000. In order to indicate possible chemical effects on humans, the base set
usually contains laboratory findings on the impact on rats following one-off administration as
well  as  administration  daily  for  28  days,  augmented  by  test  findings  on  the  irritant  and
corrosive effects on rabbits and sensitising effects on guinea pigs. In addition, test findings are
available on bacteria and cell cultures, which could provide indications of carcinogenic or
mutagenic  characteristics.  The  diversity  of  biological  species  in  human  environments  is
represented in the base set by only three freshwater organisms. The fatal effect on a species of
fish, the immobilizing effect on a species of water-flea, and the inhibition of the reproduction
of a species of green algae are each tested over 96 hours. Furthermore, data are provided on
the short-term effect on the bacteria population of a sewage treatment plant. However, the
risks for marine and terrestrial organisms remain largely impossible to assess on this basis.
The same goes for effects which only manifest themselves at the level of biocoenoses and
ecosystems. Providing a basis for exposure assessment, the base set delivers information on
substance  quantities,  use  categories,  physicochemical  characteristics  and  biological
degradability. The expectable exposure of humans and the environment has to be calculated
from this on the basis of simple, standardised scenarios and models.
The central aspect of effect assessment is the derivation of NOAEL and PNEC values. The
NOAEL (No Observed Adverse Effect Level) refers to the highest dose or concentration of a
substance for which the existing test data do not indicate any harmful effects. The NOAEL
plays a crucial role in risk assessment for humans. When assessing the risk for organisms in
the human environment, the yardstick used is PNEC (Predicted No Effect Concentration),
which is estimated from test findings taking into account an extrapolation factor designed to
express the uncertainties resulting from the transfer of laboratory data covering a few species
to the real environment (Directive 93/67). The  exposure assessment delivers not only  the
reasonably  foreseeable  exposure  level  for  humans  (concentrations  in  the  air  or  amounts
absorbed)  but  also  the  expectable  concentrations  in  certain  environmental  media  and
compartments  (e.g.  surface  water),  a  parameter  known  as  PEC  (Predicted  Environmental
Concentration).  In  risk  characterisation  ‘risk  quotients’  are  formed,  which  refer  to  the
quantitative ratio between the exposure level and the NOAEL as well as between the PEC and
the PNEC. If the assumed exposure exceeds the NOEL or the PNEC, there is always cause for
concern; otherwise there is room for discretion. Risk quotients are not an absolute measure of10
the  probability  of  harmful  effects  occurring  but  still  enable  risk  comparisons  between
different chemicals (Van Leeuwen 1995).
Risk assessment is always based on the isolated impact of one individual substance.  The
problem  of  complex  pollution  situations  involving  a  variety  of  substances  are  almost
completely  neglected  (Faust  et  al.  2000).  Risk  assessment  inevitably  contains  numerous
extrapolations, such as from ‘laboratory species’ to humans or other species, from relatively
short-term exposure to long-term pollution, and from the laboratory environment to actual
environmental  conditions.  The  inclusion  of  uncertainty  factors  in  effect  assessment,  the
assumption of a ‘reasonable worst case situation’ in exposure assessments and maintaining
margins of safety when assessing risk quotients for humans are measures intended to ensure
that, given the current state of knowledge, the findings remain on the safe side.
The competent authority responsible uses the results of the three-stage procedure to draw
conclusions which may provide a starting-point for risk management. It has different options
at its disposal depending on whether new or existing substances are being investigated. As far
as  the  new  substances  are  concerned,  the  following  four  assessment  categories  are  used
pursuant to Section 3 of Directive 93/67:
i)  No cause  for immediate concern and no  further  need  for  testing  until  additional
information is available;
ii)  Cause for concern, but further investigation only necessary once the next higher
tonnage threshold has been reached;
iii) Cause for concern; further information immediately required;
iv) Cause for concern; measures for risk reduction recommended.
According to the ECB, since the seventh amendment (1992), 56 per cent of the some 800 risk
assessments for new substances have drawn conclusion (i), 34% have stated the need for more
information when reaching the next tonnage trigger (ii), 14% called for additional information
immediately (iii), and 10% required risk reduction measures (iv).
As far as existing chemicals are concerned, the TGD (EC 1996: 8 based on Section 10 of
Regulation 793/93) provides for the following three types of conclusions:
i)  Further information needed;
ii)  No further information needed; no (other) risk reduction measures needed;
iii) Risk  limitation  required  (but  measures  already  being  applied  to  be  taken  into
account).
Nine  of  the  11  assessment  procedures  so  far  completed  saw  the  need  for  risk  reduction
measures for humans and/or the environment (iii). In the two other cases, it was felt that no
further information or action were required (ii). The dossiers on which the conclusions are
based are published for existing substances, but are kept secret for new substances.11
Risk assessment is an iterative process. Procedures, criteria and methods can and must of
necessity be constantly updated with new information and findings. This aspect is a major
subject of discussion in environmental sciences. By contrast, debate on environmental policy
currently focuses on the question over whether and when the complex methodology of risk
assessment should be used in the first place. Should risk assessment be absolutely necessary
before  restrictive  regulatory  measures  can  be  imposed?  Or  should  certain  substance
characteristics regarded as especially dangerous be considered as a sufficient argument for
restriction or even ban of a chemical, irrespective of the actual or supposed exposure level?
This approach is already used in the existing system for substances which are carcinogenic,
mutagenic and toxic for reproduction. Environmental associations are campaigning for this
strategy  to  be  enforced  and  also  broadened  to  include  other  hazardous  characteristics,
especially high persistence, high toxicity and high bioaccumulation potential (EEB 2000).
Industry is vociferously against such a move; politicians and scientists are divided.
2.4 Risk management
The  third  stage  of  chemical  regulation,  namely  decision-making  under  Directive  76/769
relating to restrictions on the marketing and use of dangerous substances, also appears in need
of  reform.  This  ‘Limitations  Directive’  is  equally  relevant  for  both  existing  and  new
chemicals, and regulates the possibilities for limiting the use of and even banning substances.
By 2001, the Directive had been amended 25 times and now covers about 900 substances. As
a rule, measures taken under this Directive simply specify controlled use, i.e. they only limit
the use of substances for certain purposes. Bans with exceptions or even complete bans such
as in the case of PCB are rare. The overwhelming majority of substances regulated in this way
are carcinogenic, and so most of the restrictions aim to protect human health (KOM 1998: 9).
The Directive’s most serious drawback is the lack of any automatic link between the risk
assessment of new and existing substances and the resulting risk management (Köck 1999:
84).  Another  complicating  factor  is  that  risk  assessment  and  risk  management  are
administratively divided at European level between DG Environment and DG Enterprise. As a
result, the extensive preliminary work undertaken by DG Environment in the form of risk
assessments and proposed risk reduction strategies are not sufficiently taken on board by DG
Enterprise  (Winter  2000:  257).  Instead,  these  documents  are  supplemented  by  DG
Enterprise’s own independent analysis of the advantages and disadvantages of the proposed
measures, resulting in additional economic and social criteria being included in the decision-
making process. In the European Commission’s view, risk assessment only provides part of
the information necessary for risk management, and therefore the Commission has undertaken
to conduct cost-benefit analyses before proposals for risk reduction affecting the chemical
industry are passed (KOM 1998: D10). On the whole this procedure appears to be suffering
from overregulation and to be unnecessarily complex. Indeed, restrictions and bans are often
only imposed after lengthy procedures lasting a number of  years for chemicals for which
member states have already taken the regulatory initiative. Krämer (2000: 25) even argues12
that there is virtually no  active Community policy regarding the banning and restriction of
dangerous substances.
3. The EU White Paper – a new strategy for European chemicals policy
The problems of European chemicals policy and how to proceed were discussed by the EU
environmental ministers at informal meetings in Chester (UK) in April 1998 and Weimar
(Germany) in May 1999. Widespread concern was voiced over the lack of progress in the risk
assessment of existing  chemicals,  and  so  the  ministers  welcomed  an  offer  by  the  former
Commissioner for the Environment Bjerregaard to submit the EU Chemicals Review, a report
on the implementation of the central Directives and Regulations of Community chemicals
policy.  The  report  was  handed  to  the  European  Commission  on  18  November  1998  and
revealed serious drawbacks in parts of European chemicals regulation.
8 In its conclusions on
chemicals policy  in  June  1999,  the  EU  Council  of  Environment  Ministers  stated  that  the
European  Community’s  current  approach  to  the  assessment  and  regulation  of  chemicals
contained a string of conceptual and operational shortcomings.
9 The Council stated the current
practice could not be expected to solve the problems stemming from existing chemicals by
adequately limiting the risks to humans and the environment. The Council accordingly called
upon  the  European  Commission  to  submit  a  proposal  for  a  new  strategy  for  European
chemicals policy by the end of 2000. The European Commission complied by submitting the
White Paper on the Strategy for a Future Chemicals Policy on 27 February 2001.
10
The White Paper sets out the European Commission’s proposals for  a  future  Community
chemicals policy designed to contribute to the overriding goal of sustainable development.
The new chemicals policy is supposed to protect the environment and human health while
ensuring the proper functioning of the single market and the international competitiveness of
the chemical industry. Given the analysis of the drawbacks of its current chemicals policy, the
European Commission is developing a new system of chemicals control comprising five key
points:
1)  The creation of a single coherent system for both existing and new chemicals by the
year 2012 with the gradual integration of existing chemicals;
2)  Shifting  the  burden  of  proof  for  testing  and  risk  assessment  from  government
agencies to chemical companies;
3)  Including  the  ‘downstream  users’  into  the  requirements  for  data  provision  and
substance testing;
4)  The introduction of an authorisation procedure for especially dangerous substances;
5)  More public openness by granting easier access to information on chemicals.
                                                
8 Working document of the Commission SEC (1998) 1986 final.
9 Conclusion  by the EU Council of Environment Ministers dated 24.6.1999, pp. 9f
10 KOM (2001) 88 final.13
3.1 REACH: the new chemicals control system
Based on the procedure for new chemicals, the White Paper calls for the creation of a uniform
system for existing and new chemicals to be set up until the year 2012. The core of this future
chemicals policy comprises a new system for chemicals control to be known as ‘REACH’
(Registration, Evaluation, Authorisation of Chemicals), which is designed to deal with the
challenge posed by the sheer quantity of existing chemicals. The REACH system consists of
three main components: registration, evaluation and authorisation (COM 2001: 16):
i)  The  registration  of  all  chemical  substances  which  are  produced  in  amounts
exceeding 1 tonne per annum. The European Commission estimates this will cover
some 30,000 substances. The basic data submitted by the chemical industry will be
stored in a central database.
ii)  The  evaluation    of  the  registered  information    for  all  substances  produced  in
quantities exceeding 100 tonnes per annum, which should account for some 5,000
substances or 15 per cent of all registered substances, as well as for substances sold
in smaller quantities if there is special cause for concern. This assessment is to be
carried  out  by  the  competent  authorities  and  will  include  the  development  of
specially tailored testing programmes.
iii) The authorisation of certain substances with  hazardous properties that give rise to
very  high  concern.  This  mainly  applies  to    substances  that  are  carcinogenic,
mutagenic and toxic for reproduction (CMR substances of categories 1 and 2
11 along
with  persistent  organic  pollutants  (POPs)  as  listed  in  the  UN  Convention).  The
number of chemical substances for which authorisation are required is estimated by
the  European  Commission  to  be  1,400,  corresponding  to  5%  of  the  registered
chemicals.
The White Paper puts forward an ambitious timetable for the transfer of existing chemical
substances to the new system (Table 2), especially bearing in mind the given experience of
the assessment of existing substances.
Table 2: Timetable in the EU White Paper for existing chemical substances
Substances produced / imported
in quantities exceeding ...
Registration dossier to
be submitted by ...




1,000 tonnes End of 2005 End of 2010 2,600
100 tonnes End of 2008 End of 2012 3,000
1 tonne End of 2012 No general official
assessment
25,000
Source: COM 2001, AHRENS 2001
                                                
11 Pursuant to the definition in Directive 67/548.14
A  report  on  the  White  Paper  by  the  British  House  of  Lords  stresses  that  many  of  those
questioned representing the agencies and stakeholders involved doubted it would be possible
to meet the registration deadlines (House of Lords 2002: notes 91f). Reservations were above
all  expressed  regarding  the  available  laboratory  capacities.  The  UK’s  Department  of  the
Environment believes the only way to meet the tight schedule would be to limit the data to be
provided to the necessary minimum.
The  European  Commission  estimates  that  testing  for  existing  chemicals  required  by  the
introduction of the new system will cost the chemical industry €2.1 billion (including the
additional personnel needed by industry). Distributed over 11 years, this will correspond to an
annual burden of €200 million. For its part, the chemical industry puts the costs of the White
Paper at €7.8 billion. Additional personnel costs will be created by the need to expand the
ECB  as  the  first  port  of  call  in  the  future.  The  European  Commission  assumes  that  the
member states will not incur any additional expenditure due to the White Paper since the
personnel  currently  tackling  other  tasks  will  be  released  to  provide  the  additional  staff
required for assessment. The White Paper emphasises that reliably estimating the total costs is
very difficult owing to the lack of experience and the uncertainties in the test data.
3.2 Registration: changes to the disclosure obligation
To close the current gaps in data on existing chemicals, the Commission rearranged the phase
of  data  provision  in  the  White  Paper.  During  registration  (the  first  step  of  the  REACH
system), the manufacturer or importer will now be obliged to inform the competent authorities
of its intention to produce or import a chemical. This registration obligation applies to all
existing and new chemicals produced or imported in quantities exceeding 1 tonne per annum.
This basic threshold is a compromise between the existing regulations for new chemicals
requiring data on quantities exceeding 10 kg to be provided, and those for existing chemicals,
under which this obligation only applies to quantities exceeding 10 tonnes (Ahrens 2001: 4).
Chemicals which the company produces or imports in quantities of less than a tonne will not
be routinely tested. This still means that of the 100,000 existing substances, 30,000 chemicals
with a marketing volume exceeding 1 tonne per annum will have to be registered by the end
of 2012. As far as new chemicals are concerned, the number of registrations will fall, since
nearly 30 per cent of new chemicals are marketed in quantities of less than a tonne. The
deadlines for the submission of registration dossiers depends on the quantities to be marketed.
In the Commission’s view, registration for chemicals exceeding 1,000 tonnes per year should
be completed by 2005, whereas those exceeding 100 tonnes only need to be completed by the
end of 2008, and the rest by the end of 2012. Registration entails submitting a dossier to the
agencies  responsible  containing  details  of  the  physico-chemical,  toxicological  and
ecotoxicological properties of the substance (hazard assessment), information enabling human
and  environmental  exposure  to  this  substance  to  be  estimated  (production  quantity,  use
categories),  a  provisional  risk  assessment  taking  into  account  its  intended  uses,  and  if
necessary  proposals  for  risk  management  measures.  The  information  submitted  will  be
centrally stored and managed on an electronic database belonging to the ECB. The general15
conformity test currently prescribed for newly registered chemicals in quantities exceeding 1
tonne per annum will in future be replaced by spot-checks and computerised screening. The
principle of quantity gradation governing the provision of further test data already provided
for in the current regulations for new chemicals (base set, level 1 testing, level 2 testing) will
largely be retained in the new chemicals policy. However, under the REACH system the base
set
12 will only be required for substances produced or imported in quantities exceeding 10
tonnes per year, the level 1 test
13 for chemicals as of 100 tonnes, and the level 2 test as of
1,000  tonnes.  However,  the  White  Paper  also  intends  to  ensure  that  the  future  system  is
flexible by not making additional tests mandatory if a new quantity threshold is reached,
dispensing  with  superfluous  testing  depending  on  chemicals’  characteristics  and  exposure
scenarios,  and  allowing  ‘substance-tailored  testing  programmes’  to  be  carried  out  (COM
2001: 13, Ahlers et al. 2001: 76).
The registration dossiers and in particular having the companies carry out provisional risk
assessment themselves relieves the national authorities of much of the time-consuming task of
collecting  data  and  carrying  out  risk  assessment  required  of  them  by  current  chemical
legislation.  In  future,  industry  will  be  responsible  for  these  tasks,  leading  to  greater
responsibility by the chemical industry for its own products. In the European Commission’s
view, this new role and responsibility should be extended to the entire processing chain for
chemicals.  The  White  Paper  therefore  also  makes  provision  for  information  rights  for
subsequent users and even ultimate consumers. Moreover, the registration dossier entails new
obligations for subsequent users, who are to provide manufacturers with details concerning
the usage of chemicals, since otherwise the authorities may call for additional tests whenever
the uses of chemicals differ from those originally envisaged by the manufacturer (COM 2001:
21). This is very likely to promote a new information and communication structure in the
chemical industry and all in all result in extensive stocks of data concerning the uses and the
health and environmental risks of 30,000 substances.
3.3 Accelerating risk assessment
Risk assessment has been redesigned by the European Commission in a number of respects.
This concerns not only the role of manufacturers, importers and users, but also that of the
competent  authorities  involved.  One  key  element  of  the  White  Paper  is  transferring  risk
assessment  from  the  official  authorities  to  the  chemical  industry.  During  registration,
companies will now have to provide a provisional risk assessment, which will merely be
verified by the agencies. Subsequent users may also be obliged to carry out additional tests
and risk assessments. The European Commission estimates that the procedure will end with
registration for 80 per cent of chemicals, with them not needing to be assessed any further.
The  competent  authorities  will  concentrate  on  the  risk  assessment  of  chemicals  sold  in
quantities exceeding 100 tonnes per annum, as well as chemicals which provide particular
                                                
12 Basic description of chemicals pursuant Annex VIIa of Directive 67/548.
13 Substance-tailored tests to determine long-term effects.16
cause for concern since they pose a health or environmental risk, irrespective of the quantities
in which they are produced or imported. The agencies will also have to decide on chemical-
specific  testing  programmes  based  on  the  information  received.  Decisions  over  necessary
additional tests will then be made by the national assessment agencies (as is already the case
in  current  legislation  for  new  chemicals).  This  mechanism  is  designed  to  overcome  the
extremely  slow,  ponderous  procedure  to  obtain  additional  test  data  for  existing  chemical
substances  under  the  EU’s  Regulation  for  existing  chemicals  (COM  2001:  24).  The
information provided during registration, the provisional risk assessment and any necessary
additional tests and data will enable the agencies to determine what chemicals are relevant
and then to carry out ‘tailored’ official risk assessment. In many cases, this will replace the
previously customary extensive risk assessment by targeted risk assessment. All in all, the
European Commission hopes to save considerable time in the risk assessment of chemical
substances by the four factors comprising the extensive provision of data during registration,
companies’ obligation to carry out an initial risk assessment, the chemical industry’s greater
responsibility for their products’ safety, and finally targeted risk assessment. The procedure
will  be  further  accelerated  by  applying  the  principle  of  precaution  in  the  case  of  unduly
delayed risk assessment processes which in particular occur when manufacturers delay the
submission of information or test data (COM 2001: 20). The precautionary principle will also
be applied if there are indications of unacceptable risks.
3.4 Improving risk management
The area of risk management has doubtless been conceptually restructured more than any
other  aspect  of  the  existing  regulations.  One  completely  new  item  is  the  proposed
authorisation procedure for substances of very high concern. For these substances, authorities
will have to give  a specific permission before they can be used for  a  particular  purpose,
marketed as such or as part of a product (COM 2001: 18). Uses which do not provide cause
for concern such as controlled use within industrial processes or  in research laboratories may
be  exempted  from  the  authorisation  procedure.  According  to  the  European  Commission,
chemicals requiring authorisation include those which are carcinogenic, mutagenic or toxic
for reproduction (CMR substances in categories 1 and 2) as well as substances with POP
characteristics under the UN Convention of persistent organic pollutants. The authorisation
procedure might also covers the vast majority of endocrine disruptive chemicals (COM 2001:
18). In the European Commission’s view, this concerns a total of 1,400 substances which
would be affected by use-related authorisation. The White Paper also keeps open the question
concerning the inclusion of other groups of chemicals such as persistent, bioaccumulative and
toxic  substances  (PBT  chemicals)  as  well  as  very  persistent  and  very  bioaccumulative
substances (vPvB chemicals).
One problem concerning the introduction of the authorisation procedure is that a considerable
proportion of chemicals subject to an authorisation obligation are currently freely available as
existing chemicals on the market, and can only be identified as particularly dangerous by
level 1 and level 2 testing. In order to solve this problem, the European Commission proposes17
introducing a two-stage decision procedure to implement the authorisation procedure (COM
2001: 19). In the first step, all substances and their special uses for which the White Paper
prescribes authorisation will be identified. Transition periods will be established, after which
all non-authorised uses of a substance will be banned. In the second step, the manufacturers
and importers can then apply for the actual authorisation for certain uses.
Authorisation is to be granted if the use merely poses a negligible risk (COM 2001: 19). The
decision is to be taken depending on the expected effects either by the competent authority of
the  responsible  Member  state  (in  charge  of  occupational  health  and  safety  or  local
environmental impact) or at EU level (for chemicals used in products). In addition, the White
Paper mentions the possibility of conditional authorisation whenever this is justified by the
socio-economic benefits arising from the use (COM 2001: 19). This evidently refers to cases
in which for example substances cannot be substituted for certain needs. In contrast to the
previous  legislation,  in  future  companies  will  have  to  present  cost-benefit  analyses
demonstrating  that  the  socio-economic  benefits  of  the  continued  usage  of  a  substance
compensate for the risks of harmful effects on human health and the environment.
Regarding substances which are not subject to the authorisation procedure but still require
measures of risk management owing to their risk assessment, the decision-making process is
to  be  accelerated  by  resorting  more  often  to  the  committee  procedure  provided  for  in
Directive  76/769  to  introduce  restrictions  or  bans  on  these  substances  in  place  of  the
previously usual complete legislative procedure.
3.5 The effectiveness of the new strategy in the White Paper
Evaluating  the  European  Commission’s  White  Paper  against  the  background  of  the
shortcomings of current chemicals regulation listed above, the  general assessment – apart
from  a  few  details  which  still  need  to  be  tidied  up  –  is  on  the  whole  very  positive.  In
producing the White Paper, the Commission has succeeded in initiating broad discussion over
future European chemicals policy. Given the considerable problems of implementation for
existing substances under current chemicals control policy, by abolishing the existing dual
system for existing and new chemicals the White Paper is pointing out the correct route to an
effective, efficient chemicals policy encouraging innovation. Thanks to the REACH system,
the new strategy contains a suitable mechanism equal to the challenge of dealing with existing
substances  with  the  limited  control  resources  available.  Compared  to  the  previous
organisation  of  the  individual  procedural  steps,  the  REACH  system  has  a  number  of
advantages regarding the procedural structure of chemicals management (Ahlers et al. 2001,
Köck 2001):
i)  It  reduces  information  gaps  affecting  existing  chemicals  relatively  quickly  by
switching to a single coherent system.
ii)  It  reduces  the  workload  of  risk  assessment  for  the  official  agencies  involved  by
transferring the burden of proof to industry owing to the introduction of provisional
risk assessment, and opens up the possibility of targeted official risk assessment.18
iii) It accelerates the decision-making process by strengthening the competences of the
national authorities in procuring information, the usage of the committee procedure
for  imposing  restrictions  on  chemicals,  the  use  of  deadlines  for  authorisation
procedures,  and  ultimately  by  exercising  the  precautionary  principle  should
insufficient data be provided by industry.
iv) It transfers the burden of intervention in the case of substances of very high concern
by  introducing  the  authorisation  procedure  and  shifting  the  burden  of  proof  to
industry.
Irrespective  of  the  reorganisation  of  the  process,  the  White  Paper  contains  new,  inter-
procedural aims for chemicals policy geared towards achieving sustainable development:
•   It  creates  incentives  for  substituting  substances  by  introducing  the  authorisation
procedure for especially hazardous chemicals, the inclusion of downstream users of
chemicals within registration and risk assessment obligations, and strengthening the
rights of consumers and the general public to information and transparency.
•   It promotes the development of the new information and communication structure by
strengthening  industry’s  own  responsibility  (manufacturers,  importers  and
downstream users).
In addition to the positive elements of the REACH system enabling the control of chemicals
to be generally organised more effectively, the new strategy for chemicals policy still contains
a number of open questions. One especially problematic aspect is that the currently relatively
well functioning notification system for new chemicals will practically be abolished owing to
the compromise between current regulations for existing and new chemicals, since 90% of
new chemicals will be below the required 10-tonne threshold and so will no longer require the
base set of data. Furthermore, the White Paper largely fails to answer the key question over
the new system regarding quality assurance for test data and provisional risk assessment. In
addition, it can also be feared that the consequences for the planned timetable resulting from
the inclusion of dowstream users in the White Paper have largely been underestimated.
4. European chemicals regulation: barrier or incentive to innovation?
4.1 Innovation effects of the procedure for existing chemicals
The  testing  and  registration  of  chemicals  inevitably  impose  costs  and  time  delays  on  the
companies concerned. The previous dual system divided into existing and new chemicals
prompted considerable evasion regarding these burdens. Innovative activity was shifted away
from the development of new chemicals requiring notification to the use of the extensive
inventory of existing substances, which  was mostly  subject to  no  restrictions  whatsoever.
R&D projects were sometimes transferred abroad. These conclusions were reached by Staudt
et al. 1993 on the basis of discussions with experts and case studies of German chemical
companies. However, the authors emphasised that the regulation of chemicals is but one of19
many determinants for such strategic corporate decisions and was therefore usually not the
main cause of such results, instead usually having a cumulative effect in conjunction with
other  factors.  Nevertheless,  this  combined  effect  still  counteracted  the  aim  of  chemicals
regulation,  namely  that  of  swiftly  advancing  the  safe  use  of  chemicals  by  obtaining
information  about  their  potentially  dangerous  characteristics.  This  failing  in  terms  of
environmental policy is to be dealt with by the White Paper by creating equal conditions for
working with existing and new substances – and hence for innovation – within 12 years. This
approach is welcomed by many stakeholders. Establishing the same conditions also includes
imported products not containing any untested substances not notified in the EU, at least such
that are released upon usage and disposal. Although the White Paper mentions this problem, it
cannot offer a specific solution to it.
4.2 Innovation effects of the procedure for new chemicals
Fleischer  et  al.  (2000)  published  a  comparative  analysis  of  the  effects  on  innovation  of
different systems for the notification of new chemicals in the EU, Japan and USA. They
reported that the Japanese system imposes much lower obligatory test requirements than the
EU system, concentrating on identifying especially persistent substances. More extensive tests
are only demanded if a test for biological degradability provides cause for concern. The US
American system does not oblige those registering chemicals to produce any sort of test data
whatsoever.  The  responsible  agency  can  only  demand  such  data  if  it  can  substantiate
suspicion  of  unreasonable  risk  in  individual  cases,  the  legal  yardsticks  being  rather  high
(GAO 1994). Fleischer et al. (2000) tried to quantify comparisons of the effects on innovation
of the three systems by using four different indicators:
i)  R&D productivity (influence of R&D expenditure on the operating result);
ii)  Patent productivity (influence of R&D expenditure on patent output);
iii) Innovation count (number of innovations reported in corporate annual reports);
iv) Notification  of  new  chemicals  (the  number  of  new  substances  registered  in  the
respective regulation system).
Although the first two indicators – R&D productivity (i) and patent productivity (ii) – indicate
US chemicals companies to be superior, the suspicion of a causal link with the regulation of
new chemicals in the USA cannot be statistically underpinned by the authors with the data
available. Counting reports of innovations by companies (iii) does not reveal any significant
difference  between  the  European,  Japanese  and  US  chemical  industry.  The  only  positive
indicator of different effects on innovation in the three regulation systems hence remains the
number of new chemicals notified annually (iv). According to Fleischer (2001:21), this is the
decisive indicator for judging how the regulation of new chemicals affects the efficiency of
innovation. Using notification statistics, Fleischer et al. (2000) calculated means covering for
the USA the period 1979–99 (21 years), for Japan 1974–98 (25 years) and for the EU 1983–
97  (15  years).  The  authors  take  into  account  different  regulations  for  the  registration20
obligation for polymers by reducing the figures for the USA by 25 per cent. As a result, they
found that in the USA an average of 425 new chemicals are notified per year, compared to
just 154 in Japan and 143 in the EU. However, this raises the question of whether these means
suitably and comparatively reflect actual developments or merely disguise them instead.
Fig. 1: Number of new chemicals notified for commercial manufacture or import per annum
Data sources: EU – European Chemicals Bureau (http://ecb.ei.jrc.it/new-chemicals/, date of access 4 October
2001).  USA  –  Fleischer  et  al.,  2000  (there  cited  as  personnel  communication  of  the  Office  of  Pollution
Prevention and Toxics of the US Environmental Protection Agency); for years 1991 to 1996 Fleischer et al.
report two different figures each, the higher ones being displayed in the figure.
The registration of new chemicals in the EU started in 1983 on the basis of the inventory of
existing chemicals previously compiled containing over 100,000 substances. The notification
figures were initially low, but grew constantly as the years progressed, and since 1996 have
stabilised at a level of over 300 new chemicals per year (Fig. 1). The US TSCA Inventory
(Toxic Substances Control Act) started four years earlier. It was also based on an inventory of
existing substances, albeit one which, containing around 62,000 chemicals, was much smaller
than its European counterpart. The number of newly marketed chemicals rose faster than in
Europe in the first few years, peaking in 1988 with around 1,000 chemicals (Fig. 1). After
1988, the figures tended to decline. Towards the end of the period surveyed (1999), they
actually converged with the European figures. This does not take account of different polymer
regulations which may justify a further the reduction of the US data by an average of 25 per






























Hence, considering the dynamics reveals a completely different impression than the simple
comparison of means. In recent years at least, these data do not demonstrate considerably
higher innovation productivity on the US chemicals market.
However, the drastically  higher  US  registration  figures  in  previous  years  remain  striking.
Secrecy of chemicals’ identities in the inventories of new substances on both sides of the
Atlantic impedes precise analysis of their content and allows much leeway for conjecturing
interpretations.  The  much  greater  ‘existing  chemicals  cushion’  in  Europe  may  be  just  as
responsible as the very different registration requirements. Due to the lack of test data, the US
EPA  (Environmental  Protection  Agency)  generally  has  to  derive  its  assessment  of  the
dangerousness of chemicals solely from their chemical structure by comparing them with the
properties of known substances with similar structures. Initially, neither sufficient databases
nor the forecasting models derived from them were available for this SAR (Structure Activity
Relationship) method. In a 12-year project, the EPA had for example 651 different chemicals
tested in terms of fish toxicity (Geiger et al. 1990) and used the results to develop structure-
effect  relations  for  numerous  groups  of  chemicals.  Hence  this  method  was  only  able  to
become effective in the late 1980s for official substance assessment. Further development in
the 1990s was accompanied by critical stocktaking which found the TSCA to be lacking in
effectiveness  regarding  the  attainment  of  the  protective  aims,  and  recommended  the  US
Congress to introduce changes more akin to the European system (GAO 1994, EDF 1997).
In contrast to these recommendations, Fleischer et al. rate the US system with its lack of test
requirements as the most efficient and most effective, and recommend its adoption by the EU
without restrictions. It must be objected, however, that the SAR method is still unable to
reliably detect the risk-relevant properties of new chemicals as efficiently as direct testing.
Within the framework of European chemical regulation it is regarded as an important aid, for
example  for  setting  priorities,  identifying  additionally  necessary  tests,  the  planning  and
quality control of experiments, and reducing the extent of animal experiments (TGD: 505 pp).
However, it is not yet suitable to completely replace experimental tests (BAuA 2001). By the
way, when comparing the regulatory systems, it should be borne in mind that the TSCA
places practically the entire burden of work and proof of risk assessment on the EPA. By
contrast, the European White Paper strategy pursues exactly the opposite aim: compelling
industry to carry out initial risk assessment, and encouraging innovation designed to boost
efficiency of hazard and risk assessment procedures to become aims of industry.
4.3 Scope for innovation from exemption rules and quantity thresholds
Staudt  et  al.  (1997)  also  examined  the  extent  to  which  minor  changes  to  the  existing
regulatory  framework  could  open  up  innovation  scope  for  chemical  companies.  They
concluded that this is possible to a considerable degree without having to give up protective or
precautionary  aims.  They  collected  arguments  from  companies  and  agencies  regarding
contentious regulatory items. After balancing the arguments, they identified three areas where
barriers to innovation could be removed without losing the protection aims:22
i)  Expanding the special exemptions from the notification procedure for substances
which are only used for scientific or process-orientated R&D;
ii)  Reducing the testing programme and targeted risk assessment for substances which
are only to be used for further processing within the chemical industry (‘intermediate
products’);
iii) Simplifying  regulations  for  the  notification  of  polymers  (group  registration  of
polymer varieties or the dependence of notification on certain hazard indications).
Whereas  the  ‘polymer  dilemma’  still  appears  unsolved,  progress  appears  to  have  been
achieved  regarding  the  other  two  items.  The  White  Paper  strategy  makes  provision  for
increasing the registration quantity threshold for chemicals used for scientific R&D from 100
kg to 1 tonne, as well as for extending the exemption deadline for substances in process-
orientated R&D from 1 year to 3–5 years. Regarding strictly controlled intermediate products,
the  28th  amendment  designed  to  bring  Directive  67/548  in  step  with  technical  progress
provides for a reduced test programme. This change will come into force in summer 2002.
Whether the expectations of greater innovation will be fulfilled remains to be seen.
According  to  Fleischer  et  al.  (2000:  154f),  the  high  registration  costs  for  new  chemicals
compared  to  the  USA  and  Japan,  especially  for  substances  with  relatively  low  market
volumes, contain considerable potential for limiting  innovation  and  distorting  competition
compared to the Japan and the USA. They therefore recommend raising the quantity threshold
for basic testing from 1 tonne to 10 tonnes. This is in fact provided for by the White Paper
strategy, albeit for another reason. The tonnage thresholds for experimental tests need to be
raised if there is to be any realistic chance of dealing with a reasonable proportion of existing
chemicals within the proposed 12-year plan. The 10-tonne threshold suggested will result in
approximately 10,000 existing substances remaining for which at least the base set will have
to be provided. In 12 years, this will mean an average of some 830 chemicals tests per year
being  additionally  incurred.  The  only  reason  for  raising  the  tonnage  threshold  for  new
chemicals  requiring  a  base  set  from  1  tonne  to  10  tonnes  is  as  a  countermove  to  ensure
equality. Hence relief in the area of new chemicals is offset by additional burdens regarding
existing chemicals. However, it is almost impossible to assess any sort of net possible effect
on future innovation productivity on this basis. Then again, clear new scope would result from
raising the quantity threshold whenever the development of new substances were planned
right from the start for special applications in relatively low quantities.
There is however resistance to dealing with existing substances at the expense of reduced
informations on new chemicals. In its joint paper drawn up with the VCI and the IGBCE
(Mining,  Chemical  and  Energy  Industrial  Union)  dated  11  March  2002,  the  German
government urged that at least a reduced dataset be demanded for substances produced or
imported  in  amounts  of  1–10  tonnes  per  annum,  providing  information  in  the  event  of
accidental  release  and  for  occupational  safety.  Other  member  states  and  groups  of
stakeholders have echoed this view. Therefore, considerable cost reduction for companies in
connection with new chemicals appears unlikely.23
In addition, raising the threshold tonnage for new chemicals may in actual fact run counter to
the aim of the White Paper of creating conditions and incentives for the substitution of high-
risk chemicals by low-risk ones. This aspect is dealt with below.
4.4 Directing innovation towards  sustainability
The point of regulating chemicals is to protect human health and the environment. The current
regulation  of  new  chemicals  is  based  on    identifying  the  hazards  and  risks  attached  to
chemicals early on. It is tied to the political expectation that this will encourage innovation
towards  less  risky  or  ideally  completely  safe  chemical  products  and  procedures.  An
assessment of innovation productivity which completely ignores these aims and simply rates
each new substance on the market as marking innovative progress misses the central point of
chemicals regulation and the attempts to make it more effective. It would have to end in the
trivial conclusion  that  all  the  costs  connected  with  registration  could  lead  to  a  barrier  to
innovation,  since  it  cannot  place  the  costs  in  relation  to  the  desired  benefits  for  the
preservation  of  human  health  and  environmental  resources.  This  sums  up  the  clear
weaknesses of previous studies on how chemicals regulation affects innovation. However, it
must be admitted that methodological problems and the lack of suitable databases have so far
largely  stood  in  the  way  of  the  comparative  cost-benefit  analysis  of  different  regulatory
systems or regulatory options.
The current regulatory systems for new chemicals in both the USA and the EU have focused
on identifying and isolating especially hazardous and  risky  chemicals. The White Paper’s
strategy  goes  one  step  further  by  rating  the  substitution  of  hazardous  chemicals  by  safer
substances as a new, important  goal. However, substitution  decisions  require  comparable,
generally accepted bases for discussion which enable a new substance to be classified in a
comprehensible manner as relatively low-risk. The system of rigid test requirements in the EU
criticised as inefficient by Fleischer et al. (2000) ensures the provision of such a basis of
information, at least for substances with a production volume of at least 1 tonne per annum.
This also provides an important way of pursuing innovation productivity geared towards the
desired minimisation of the conflict between economic and ecological aims.
So far, the information situation for new chemicals has proved favourable for advancing the
substitution approach. It was on this basis for example that the Federal German Agency for
Labour  Safety  and  Occupational  Medicine  began  publishing  lists  of  recommendable
substances  for  certain  purposes  and  areas.  They  contain  chemicals  which  during  the
notification  procedure  were  not  found  to  have  any  dangerous  properties  necessitating
classification and labelling, and for which no indications of toxic effects have been found
which  could  provide  cause  for  concern  (BAuA  1999).  As  new  chemicals  are  generally
initially used in low market volumes, it is important for such promotion strategies that the
tonnage  thresholds  for  test  requirements  also  be  set  relatively  low.  However,  based  on
previous experience, the uniform rise from 1 to 10 tonnes proposed in the White Paper would
mean  that  some  90%  of  the  substances  would  drop  below  the  threshold  required  for  the24
production of a base set of data. And this could knock the bottom out of the substitution
approach.
Substance identity and test data from the new chemicals procedure are currently subject to
strict secrecy. The public and users are expected to trust the results, while valuable collections
of  information  for  the  validation  and  development  of  methods  and  models  for  predictive
hazard  assessment  remain  off-limits  to  environmental  scientists.  Furthermore,  the  quality
assurance  of  secret  data  is  also  beset  by  serious  problems.  Occasionally  re-analyses  of
datasets  made  anonymous  have  in  some  cases  revealed  considerable  shortcomings  in  the
performance of biological tests as well as the statistical evaluation of experimental data (Ratte
1998). Therefore the question has also been raised as to whether transparency and publicity
are perhaps important and effective elements of an environmental innovation strategy in the
chemicals sector. Experience with the Toxic Release Inventory in the USA has shown that
merely  the  free  availability  of  information  can  release  enormous  stimulus  towards  the
reduction of environmental pollution (EDF 1997). This effect could also be useful to increase
the safety of chemicals and to boost environmentally innovative chemical applications. The
initial approaches outlined in the White Paper move in this direction, but the protection of
property  rights  to  substance  and  exposure  data  currently  appears  to  be  an  almost
insurmountable obstacle. Solutions need to be found in order to push ahead with innovation
for sustainable economic activity.
5. Concluding remark
On closer examination, there is no conclusive proof for the claim that the current European
regulation of the chemicals tends to discourage innovation. It is the current regulatory pattern
involving separate regulation for existing and new substances which has resulted in evasive
possibilities slowing down innovation. The strategy contained in the White Paper for unifying
the level of information required for existing and new chemicals is designed to close the gap.
It defines the aim of sustainable development as a desirable direction of innovation, although
its strategy for achieving this aim remains largely focused on impeding market access for
risky chemicals and hence fostering the pressure for environmentally orientated innovation.
Simultaneously, it is intended to expand the scope for innovation by raising the threshold
values for test requirements and enlarging the conditions for exceptions in R&D. These are
important steps for sharpening the focus on innovation of chemicals policy.
From  the  perspective  of  encouraging  innovation,  one  of  the  main  things  still  missing  is
approaches  for  the  complementary  development  of  positive  innovation  incentives  by
strengthening market chances for relatively low-risk chemicals and processes. The threat of
restrictions  has  proved  necessary  in  the  past,  but  is  by  itself  a  ponderous  means  for
implementing environmental policy aims. The idea is to make it pay for companies to pursue
environmentally  focused  innovation  strategies.  For  this  purpose,  supporting  measures  and
instruments need to be further developed.25
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